NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fida Biosystems

Fida Biosystems

Private
DenmarkHealthcare & Life Scienceshttps://www.fidabio.com/

Last Round

Series A

Extension

Dec 16, 2025

Total Funding Raised

$9.36M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Fida Biosystems is a biotechnology company that develops advanced analytical platforms based on its proprietary Flow Induced Dispersion Analysis (FIDA) technology for biophysical analysis of biomolecules and nanoparticles.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

biomolecular interaction analysisprotein characterizationflow induced dispersion analysisFIDAbiotech instrumentationbinding affinitylabel-free analysisdrug discovery toolsprotein engineeringbiotech lab equipmentanalytical chemistrylife sciences toolswet lab automationbiophysical analysislab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fida Biosystems Comparables

Compare Fida Biosystems with similar companies based on industry and business-model similarity.

Fida Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Fida Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 16, 2025
GrantMay 29, 2020
Series ADec 18, 2019
GrantDec 1, 2019

Key People

Founding team and executive leadership

Niels Kristian Bau-Madsen

CTO

Executive Team

Fida Biosystems Investors

Notable investors and investment history

Fida Biosystems investors
InvestorRounds
Innovation Fund DenmarkGrant
Fåhraeus Startup and GrowthSeries A Extension
The Export and Investment Fund of DenmarkSeries A Extension, Series A
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 17, 2025

    $5.4M round led by Fåhraeus Startup and Growth.

  • May 15, 2025

    Added Eisai GmbH, a pharmaceutical company, as a customer.

Fida Biosystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fida Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fida Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenmark
Employee Range38
Year Founded2013
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.